Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
TCM Senior Cash Management Specialist INSURGENTES Mexico Operations CTS Audit & Finance Aug 30, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Buyer LACan (Temporary) INSURGENTES Mexico Operations CTS Procurement Sep 15, 2024
Specialist - Quality Operations (APQR) INSURGENTES Mexico Operations Innovative Medicines Quality Sep 27, 2024
Procure to Pay Business Partner GDD and M&A SPOC INSURGENTES Mexico Operations CTS Audit & Finance Sep 27, 2024
Data Engineering Manager - Data Services Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 26, 2024
Automation Engineer II Durham USA Operations Innovative Medicines Technical Operations Sep 26, 2024
Senior Specialist DDIT ISC Detection & Response INSURGENTES Mexico Operations CTS Technology Transformation Sep 26, 2024
Sr. Specialist DDIT ISC CSOC Engineering INSURGENTES Mexico Operations CTS Technology Transformation Sep 26, 2024
Associate Director DDIT ISC CSOC Onboarding INSURGENTES Mexico Operations CTS Technology Transformation Sep 26, 2024
Associate Director DDIT ISC Detection & Response INSURGENTES Mexico Operations CTS Technology Transformation Sep 26, 2024
Labortechniker / QC Analyst II (m/w/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Sep 26, 2024
QC Specialist II (m/w/d) Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality Sep 26, 2024
Assoc. Director DDIT ISC IES Hyderabad (Office) India Operations CTS Technology Transformation Sep 26, 2024
Vodja skupine kontrole kakovosti v QLS Velike Molekule / Vodja laboratorija Bioanalitika (m/f/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Sep 27, 2024
Drawing & Documentation-Executive Hyderabad (Office) India Operations Innovative Medicines Technical Operations Sep 27, 2024
GCP/PV Auditor Barcelona Provincial Spain Operations Innovative Medicines Quality Oct 14, 2024
RLT Regional Logistics Lead - AMERICAS INSURGENTES Mexico Operations Innovative Medicines Technical Operations Oct 14, 2024
QA Operations Expert Kundl Austria Operations Innovative Medicines Quality Oct 14, 2024
IT Solution Delivery Manager Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 14, 2024
Senior Analyst - Patient Analytics Hyderabad (Office) India Operations CTS Marketing Oct 14, 2024
Procurement Senior Process Excellence Specialist Prague Czech Republic Operations CTS Procurement Oct 11, 2024
Assoc. Dir. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Oct 11, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Oct 11, 2024
Sr Specialist - DevOps Engineer Hyderabad (Office) India Operations CTS Technology Transformation Oct 11, 2024
Real Estate Lead, Data & Technology Prague Czech Republic Operations CTS Facilities & Administration Oct 11, 2024
Associate Director, IT Site Business Partner for Technical R&D Ivrea Italy Operations Innovative Medicines Technology Transformation Oct 11, 2024
Tech Transfer Lead Schaftenau Austria Operations Innovative Medicines Technical Operations Sep 03, 2024
Global Statistics / PAT Lead Hyderabad (Office) India Operations Innovative Medicines Technical Operations Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist – QOP Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
E2E Supply Network Planning Manager Hyderabad (Office) India Operations Innovative Medicines Technical Operations Oct 14, 2024
Regional Procurement Category Manager Real Estate Prague Czech Republic Operations CTS Procurement Oct 15, 2024
Specialist, Operations ITOT Automation Engineer Ivrea Italy Operations Innovative Medicines Technical Operations Oct 15, 2024
Quality Compliance Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality Oct 15, 2024
Data Steward, Hyderabad (Office) India Operations CTS Marketing Oct 15, 2024
Solution Delivery Architect Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 15, 2024
IT Project Manager Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 15, 2024
Legal Trainee - Novartis Operations Basel (City) Switzerland Operations CTS Others Oct 15, 2024
Tehnik vzdrževanja (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 15, 2024
Ekspert upravljanja kakovosti zunanjih dobaviteljev (m/ž/d) / Quality Assurance Manager for external suppliers (m/f/d) (ESO FDF II) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 15, 2024
Specialist IT Risk Assurance Hyderabad (Office) India Operations CTS Technology Transformation Oct 15, 2024
Assoc Director - Service Management (ITIL , ITSM - Salesforce) Hyderabad (Office) India Operations CTS Technology Transformation Oct 15, 2024
Novartis Operation Corporate Center (NOCC) Mexico City Head INSURGENTES Mexico Operations CTS Commercial & General Management Oct 15, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only